These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 26195201)

  • 21. [Minimal hepatic encephalopathy].
    Jover M; Hoyas E; Grande L; Romero-Gómez M
    Rev Gastroenterol Mex; 2009; 74(1):26-34. PubMed ID: 19666316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebral blood flow measured by arterial-spin labeling MRI: a useful biomarker for characterization of minimal hepatic encephalopathy in patients with cirrhosis.
    Zheng G; Zhang LJ; Zhong J; Wang Z; Qi R; Shi D; Lu GM
    Eur J Radiol; 2013 Nov; 82(11):1981-8. PubMed ID: 23849331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management options for minimal hepatic encephalopathy.
    Bajaj JS
    Expert Rev Gastroenterol Hepatol; 2008 Dec; 2(6):785-90. PubMed ID: 19090738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in the evaluation and management of minimal hepatic encephalopathy.
    Montgomery JY; Bajaj JS
    Curr Gastroenterol Rep; 2011 Feb; 13(1):26-33. PubMed ID: 20924726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minimal hepatic encephalopathy.
    Stewart CA; Smith GE
    Nat Clin Pract Gastroenterol Hepatol; 2007 Dec; 4(12):677-85. PubMed ID: 18043677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Critical flicker frequency for diagnosis and assessment of recovery from minimal hepatic encephalopathy in patients with cirrhosis.
    Sharma P; Sharma BC; Sarin SK
    Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):27-32. PubMed ID: 20133225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical importance and diagnostic methods of minimal hepatic encephalopathy].
    Stawicka A; Zbrzeźniak J; Świderska A; Kilisińska N; Świderska M; Jaroszewicz J; Flisiak R
    Pol Merkur Lekarski; 2016 Feb; 40(236):117-21. PubMed ID: 27000818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered response to oral glutamine challenge as prognostic factor for overt episodes in patients with minimal hepatic encephalopathy.
    Romero-Gómez M; Grande L; Camacho I; Benitez S; Irles JA; Castro M
    J Hepatol; 2002 Dec; 37(6):781-7. PubMed ID: 12445419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimal hepatic encephalopathy in patients with liver cirrhosis: magnetic resonance spectroscopic brain findings versus neuropsychological changes.
    Hassan EA; Abd El-Rehim AS; Seifeldein GS; Shehata GA
    Arab J Gastroenterol; 2014; 15(3-4):108-13. PubMed ID: 25459346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review article: the modern management of hepatic encephalopathy.
    Bajaj JS
    Aliment Pharmacol Ther; 2010 Mar; 31(5):537-47. PubMed ID: 20002027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimal hepatic encephalopathy: time to recognise and treat.
    Dhiman RK; Chawla YK
    Trop Gastroenterol; 2008; 29(1):6-12. PubMed ID: 18564660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3-nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis.
    Montoliu C; Cauli O; Urios A; ElMlili N; Serra MA; Giner-Duran R; González-Lopez O; Del Olmo JA; Wassel A; Rodrigo JM; Felipo V
    Am J Gastroenterol; 2011 Sep; 106(9):1629-37. PubMed ID: 21483460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective evaluation of the impact of covert hepatic encephalopathy on quality of life and sleep in cirrhotic patients.
    Labenz C; Baron JS; Toenges G; Schattenberg JM; Nagel M; Sprinzl MF; Nguyen-Tat M; Zimmermann T; Huber Y; Marquardt JU; Galle PR; Wörns MA
    Aliment Pharmacol Ther; 2018 Aug; 48(3):313-321. PubMed ID: 29863286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patients with minimal hepatic encephalopathy have poor insight into their driving skills.
    Bajaj JS; Saeian K; Hafeezullah M; Hoffmann RG; Hammeke TA
    Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1135-9; quiz 1065. PubMed ID: 18928938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimal hepatic encephalopathy.
    Dhiman RK; Chawla YK
    Indian J Gastroenterol; 2009; 28(1):5-16. PubMed ID: 19529896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence of persistent cognitive impairment after resolution of overt hepatic encephalopathy.
    Riggio O; Ridola L; Pasquale C; Nardelli S; Pentassuglio I; Moscucci F; Merli M
    Clin Gastroenterol Hepatol; 2011 Feb; 9(2):181-3. PubMed ID: 20951832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of life in patients with minimal hepatic encephalopathy.
    Ridola L; Nardelli S; Gioia S; Riggio O
    World J Gastroenterol; 2018 Dec; 24(48):5446-5453. PubMed ID: 30622374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of minimal hepatic encephalopathy (with emphasis on computerized psychometric tests).
    Kappus MR; Bajaj JS
    Clin Liver Dis; 2012 Feb; 16(1):43-55. PubMed ID: 22321464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum nitrotyrosine and psychometric tests as indicators of impaired fitness to drive in cirrhotic patients with minimal hepatic encephalopathy.
    Felipo V; Urios A; Valero P; Sánchez M; Serra MA; Pareja I; Rodríguez F; Gimenez-Garzó C; Sanmartín J; Montoliu C
    Liver Int; 2013 Nov; 33(10):1478-89. PubMed ID: 23714168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minimal hepatic encephalopathy is associated with falls.
    Román E; Córdoba J; Torrens M; Torras X; Villanueva C; Vargas V; Guarner C; Soriano G
    Am J Gastroenterol; 2011 Mar; 106(3):476-82. PubMed ID: 20978484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.